insights_auto
Why is RXRX down 3.14%?
Dive Deeperchevron_right
RXRX:NASDAQ
Recursion Pharmaceuticals Inc
$4.63
arrow_downward
-3.14%(-0.15) 1D
$4.64
arrow_upward
+0.22% (+0.0100)bedtimeAfter hours
Closed: Oct 6, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RXRX...
Open
$4.81
High
$5.19
Low
$4.40
Mkt. cap
2.14B
Avg. vol.
20.66M
Volume
70.83M
52-wk high
$7.18
52-wk low
$2.77
EPS
-$1.04
Beta
1.04
Shares outstanding
535.34M
No. of employees
600
Open
$4.81
High
$5.19
Low
$4.40
Mkt. cap
2.14B
Avg. vol.
20.66M
Volume
70.83M
52-wk high
$7.18
52-wk low
$2.77
EPS
-$1.04
Beta
1.04
Shares outstanding
535.34M
No. of employees
600
News stories
From web sources and news partners
StocksToTrade
·
1 hour ago
RXRX Stock Grinds Higher As Traders Focus On Runway And Range
Kalkine Media
·
3 hours ago
Recursion Pharmaceuticals Director Hershberg to Sell 25,000 Shares via Option Exercise
Stock Titan
·
4 hours ago
A 50,000-share sale is proposed by director Blake C. Borgeson at Recursion (RXRX).
About Recursion Pharmaceuticals Inc
CEONajat Khan
Employees600
Founded2013
HeadquartersSalt Lake City, Utah, United States
SectorBiotechnology
Websiterecursion.com